Paper786455
Mitomycin C: a review.
Crooke ST and 1 other. Cancer Treat Rev, 1976. Cited by 486 papers, by iCite.
Cite this record
ConductScience Library. Mitomycin C: a review. Papers, record 786455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/786455
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mitomycins | Major topic |
| Neoplasms | Major topic |
| Animals | |
| DNA | |
| Drug Administration Schedule | |
| Drug Resistance, Microbial | |
| Humans | |
| Immunosuppression Therapy |
Source PubMed
Cited by93
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 486 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41938163 | Sulfone-quinone derivatives: a review on their synthetic methods, properties and applications. | RSC Adv | 2026 | https://conductscience.org/library/papers/41938163 | PubMed |
| 41514559 | Systemic Chemotherapy in Penile Squamous Cell Carcinoma: Mechanisms, Clinical Applications, and Evidence-Based Regimens. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41514559 | PubMed |
| 41491222 | Targeting the DNA damage response prevents regrowth of colorectal peritoneal metastasis-derived organoids following treatment with mitomycin C. | Br J Cancer | 2026 | https://conductscience.org/library/papers/41491222 | PubMed |
| 41228359 | Mitomycin-C for HPV-Positive and HPV-Negative Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41228359 | PubMed |
| 41199376 | Mitomycin C-induced DNA double-strand breaks are enhanced by catalytical inactivation of DNA polymerase κ in mice. | Genes Environ | 2025 | https://conductscience.org/library/papers/41199376 | PubMed |
| 40855509 | The isoflavone genistein selectively stimulates major satellite repeat transcription in mouse heterochromatin. | Epigenetics Chromatin | 2025 | https://conductscience.org/library/papers/40855509 | PubMed |
| 40809697 | Gynecologic postoperative anti-adhesion barriers: From biomaterials to barrier development. | Biomater Biosyst | 2025 | https://conductscience.org/library/papers/40809697 | PubMed |
| 40525407 | Combination of mitomycin C and low-dose metronidazole synergistically against Clostridioides difficile infection and recurrence prevention. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40525407 | PubMed |
| 40351281 | Unveiling the research directions for pyrrolidine-based small molecules as versatile antidiabetic and anticancer agents. | Future Med Chem | 2025 | https://conductscience.org/library/papers/40351281 | PubMed |
| 40292320 | A high-throughput differential chemical genetic screen uncovers genotype-specific compounds altering plant growth. | iScience | 2025 | https://conductscience.org/library/papers/40292320 | PubMed |
| 39731542 | Discovery of a Chimeric Polyketide Family as Cancer Immunogenic Chemotherapeutic Leads. | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/39731542 | PubMed |
| 38279745 | Phytotherapeutics in Cancer: From Potential Drug Candidates to Clinical Translation. | Curr Top Med Chem | 2024 | https://conductscience.org/library/papers/38279745 | PubMed |
| 38088585 | Secondary 3-Chloropiperidines: Powerful Alkylating Agents. | ChemistryOpen | 2024 | https://conductscience.org/library/papers/38088585 | PubMed |
| 38036976 | Screening of Natural Compounds for CYP11A1 Stimulation Against Cell Renal Cell Carcinoma. | Biol Proced Online | 2023 | https://conductscience.org/library/papers/38036976 | PubMed |
| 37996570 | Quinones from Cordia species from 1972 to 2023: isolation, structural diversity and pharmacological activities. | Nat Prod Bioprospect | 2023 | https://conductscience.org/library/papers/37996570 | PubMed |
| 37980694 | Three-membered ring formation catalyzed by α-ketoglutarate-dependent nonheme iron enzymes. | J Nat Med | 2024 | https://conductscience.org/library/papers/37980694 | PubMed |
| 37635891 | A Randomized Control Trial to Evaluate the Effect of Local Instillation of Mitomycin-C at the Porta after Kasai Portoenterostomy in Patients of Biliary Atresia. | J Indian Assoc Pediatr Surg | 2023 | https://conductscience.org/library/papers/37635891 | PubMed |
| 37397557 | Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. | Genes Dis | 2023 | https://conductscience.org/library/papers/37397557 | PubMed |
| 35743251 | Use of Self-Assembled Colloidal Prodrug Nanoparticles for Controlled Drug Delivery of Anticancer, Antifibrotic and Antibacterial Mitomycin. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35743251 | PubMed |
| 35704159 | Topical Chemotherapy for Treating Ocular Surface Squamous Neoplasia with a Combination of Interferon α-2b and 5-Fluorouracil. | Ophthalmol Ther | 2022 | https://conductscience.org/library/papers/35704159 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/786455
GET https://conductscience.org/api/papers/v1/786455/cited_by?page=2